Currently out of the existing stock ratings of Michael Morabito, 30 are a BUY (100%).

Michael Morabito

Work Performance Price Targets & Ratings Chart

Analyst Michael Morabito, carries an average stock price target met ratio of 38.33% that have a potential upside of 32.78% achieved within 214 days. Previously, Michael Morabito worked at CHARDAN CAPITAL, CREDIT SUISSE.

Michael Morabito’s has documented 56 price targets and ratings displayed on 11 stocks. The coverage was on Healthcare, Industrials, Financial Services sectors.

Most recent stock forecast was given on DRRX, Durect at 05-May-2021.

Wall Street Analyst Michael Morabito

Analyst best performing recommendations are on ETN (EATON PLC).
The best stock recommendation documented was for ETN (EATON PLC) at 9/15/2020. The price target of $95 was fulfilled within 2 days with a profit of $1.88 (2.02%) receiving and performance score of 10.09.

Average potential price target upside

DRRX Durect ETN Eaton PLC MRTX Mirati Ther VKTX Viking Therapeutics AXLA Axcella Health AKRO Akero Therapeutics CWBR CohBar ICPT Intercept Pharmaceuticals MGNX MacroGenics NGM NGM Biopharmaceuticals AX Axos Financial

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 14-Sep-2023

$2.5

$0.59 (30.89%)

1 years 2 months ago
(29-Jul-2025)

0/2 (0%)

$0.62 (32.98%)

Hold Since 28-Mar-2024

1 years 6 months 2 days ago
(27-Mar-2025)

0/5 (0%)

$27.19 (565.28%)

Buy Since 22-Jan-2020

$5

$3.09 (161.78%)

$32

2 years 5 months 28 days ago
(01-Apr-2024)

0/6 (0%)

$3.89 (350.45%)

Buy Since 04-Mar-2020

3 years 1 months 19 days ago
(10-Aug-2023)

0/4 (0%)

$27.7 (101.47%)

Buy Since 05-May-2021

3 years 1 months 19 days ago
(10-Aug-2023)

0/1 (0%)

$42.3 (238.98%)

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?